CTN :40951159
31 Jul, 2025
8.00 Crore
Tender For rate contract of drugs and medicines - rate contract of medicines :-, lignocaine and adrenaline ext-red-selected">inj. 20mg + 0.01mg 30 ml vial, anti thymocyt
e globulin, growth harmon
e, imip
enum + cilastatin 500, l-carnitin
e, nandrolon
e 25 mg, n
etilmicin 100 mg, n
etilimicin 200 mg, n
etilimicin 300 mg., n
etilmicin 10 mg, palonos
etron 1.5ml, t
estost
eron
e propionat
e 250 mg (
enantat
e) / ml, tobramycin 20 mg, vitamin b1 + b6 + b12, voriconazol
e lypholis
ed 200, amikacin
ext-r
ed-s
el
ect
ed">inj
ection 2 ml vial 500 mg, mupirocin skin ointm
ent, plast
er of paris i.p .in 25kg .bag in polyth
en
e lin
ed hdp
e moistur
e and ins
ect proof bag), plast
er of paris i.p .in 50kg. bag in polyth
en
e lin
ed hdp
e moistur
e and ins
ect proof bag, protin powd
er 225 gm, form
etrol + fluticoson
e 200/ 400 r/ c, 0.55% w/wortho - phthalald
ehyd
e (1,2-b
enz
en
e di carboxald
ehyd
e) solution, usfda & us
ep aapprov
ed, ndors
ed by r
eput
ed manufactur
ers of m
edical, 1% availabl
e iodin
e with surfactant for skin pr
eparationand cl
eaning, carbolicacid (ph
enol) 400 ml, low foam
enzymatic d
et
erg
ent solutioncontaining four
enzym
es : bact
erialprot
eas
e, alpha-amylas
e, lipas
e, c
ellulas
e, sodium t
etraborat
e d
ecahydrat
e, us
epa/ usfda approv
ed 3.78 ltr bottl
e, surfac
e,
environm
entandinstrum
ent disinf
ectant (did
ecyl dimithyl ammonium chlorid + glut
eral + glyoxal disinf
ectant)1lit., disodium hydrog
en citrat
e, cyproh
eptadin
e syp, bcompl
ex syrup 100 ml, amoxycillin and potassium clavulanat
e tabs 500 mg + 125 mg, f
exof
enidin
e 120 mg, f
exof
enidin
e 180 mg, isoniazid 300 mg, amoxicillin and clavulanic acid
ext-r
ed-s
el
ect
ed">inj
ection 600 mg, mycoph
enolat
e mof
etil500 mg, amoxicillin and potassium clavulanat
e ext-r
ed-s
el
ect
ed">inj
ection 1.2 gm, tacrolimus 1 mg, ampicillin capsul
e 500 mg, acarbos
e 25 mg, cap
ecitabin
e 500 mg, carv
edilol 3.125 mg, chlothalidon
e 6.25 mg, chlothalidon
e 12.5 mg, bupivacain
e hydrochlorid
e in d
extros
e ext-r
ed-s
el
ect
ed">inj
ection 5mg + 80 mg p
er ml, alfuzosin 10 mg, dutast
erid
e 0.5 mg, lacosamid
e 100mg, tab. chlorthalidon
e 12.5mg, c
efop
erazon
e and sulbactum for
ext-r
ed-s
el
ect
ed">inj
ection 1 g + 0.5 g, c
efotaxim
e ext-r
ed-s
el
ect
ed">inj
ection 1 g, c
eftazidim
e ext-r
ed-s
el
ect
ed">inj
ection 1 g, c
eftazidim
e ext-r
ed-s
el
ect
ed">inj
ection 500 mg, c
eftriaxon
e ext-r
ed-s
el
ect
ed">inj
ection ip 1 g/ vial, c
eftriaxon
e ext-r
ed-s
el
ect
ed">inj
ection ip 500 mg/ vial, c
efuroxim
e tabl
et 250 mg, ciprofloxacin
ext-r
ed-s
el
ect
ed">inj
ection 200 mg/ 100 ml, ofloxacin
ext-r
ed-s
el
ect
ed">inj
ection 200mg / 100 ml, co-trimoxazol
e oral susp
ension ip
each 5 ml contains trim
ethoprim 40 mg and sulpham
ethoxazol
e 200 mg, doxycyclin
e capsul
e 100 mg, tramadol capsul
e 50 mg, vancomycin
ext-r
ed-s
el
ect
ed">inj
ection 500 mg, aztr
eonam 1gm
ext-r
ed-s
el
ect
ed">inj
ection, tramadol
ext-r
ed-s
el
ect
ed">inj
ection 50 mg/ ml, m
etronidazol
e ext-r
ed-s
el
ect
ed">inj
ection 500 mg/ 100 ml, m
etronidazol
e b
enzoat
e oral susp
ension 100 mg/ 5 ml, alb
endazol
e oral susp
ension 400 mg/ 10 ml, clotrimazol
e cr
eam ip 2% w/ w, fluconazol
e tabl
et 150 mg, amphot
ericin b
ext-r
ed-s
el
ect
ed">inj
ection 50 mg, artisunat
e ext-r
ed-s
el
ect
ed">inj
ection 60 mg (combo pack with 1 ml ampoul
e of 5% sodium bicarbonat
e ext-r
ed-s
el
ect
ed">inj
ection and 5 ml ampoul
e of 0.9% sodium chlorid
e ext-r
ed-s
el
ect
ed">inj
ection), acyclovir tabl
et 200 mg, acyclovir tabl
et 800 mg, acyclovir susp
ension 400 mg/ 5ml, bl
eomycin
ext-r
ed-s
el
ect
ed">inj
ection 15 units, cyclophosphamid
e ext-r
ed-s
el
ect
ed">inj
ection 200 mg, cyclophosphamid
e ext-r
ed-s
el
ect
ed">inj
ection ip 500 mg, cytarabin
e ext-r
ed-s
el
ect
ed">inj
ection 100 mg/ 5 ml, fluorouracil
ext-r
ed-s
el
ect
ed">inj
ection 250 mg/ 5 ml, m
ethotr
exat
e ext-r
ed-s
el
ect
ed">inj
ection 50 mg/ 2 ml, tamoxif
en tabl
et 10 mg, vinblastin
e ext-r
ed-s
el
ect
ed">inj
ection 10 mg/ 10 ml, vincristin
e ext-r
ed-s
el
ect
ed">inj
ection 1 mg/ ml,
ext-r
ed-s
el
ect
ed">g
emcitabin
e ext-r
ed-s
el
ect
ed">inj
ection 200 mg, imatinib tabl
et 400 mg, m
ethotr
exat
e tabl
et ip 10 mg, mitomycin c
ext-r
ed-s
el
ect
ed">inj
ection 10 mg, diclof
enac g
el: diclof
enac di
ethylamin
e , m
ethyl salicylat
e , lins
eed oil and m
enthol 1.16%+10%+3%+ 5%, 20gm,
ext-r
ed-s
el
ect
ed">inj. b
evacizumab 400 mg,
ext-r
ed-s
el
ect
ed">inj. b
evacizumab 100 mg, diclof
enac sodium
ext-r
ed-s
el
ect
ed">inj
ection - for im and iv 25 mg/ ml, warfarin sod. tabl
et 5 mg, tran
examic acid tabl
et 500 mg, dri
ed factor viii fraction (iv us
e) 250 iu, k
etamin
e ext-r
ed-s
el
ect
ed">inj
ection 50 mg/ ml, dri
ed factor viii fraction (iv us
e) 500 iu, factor ix conc
entrat
e 600 iu, anti- inhibitor coagulation compl
ex [human plasma prot
ein with a factor viii inhibitor bypassing activity of 500 i.u. p
er vial 500 iu], d
ef
eripron
e capsul
e 500 mg, rh-
erythropo
etin
ext-r
ed-s
el
ect
ed">inj
ection 2000 iu, rh-
erythropo
etin
ext-r
ed-s
el
ect
ed">inj
ection 40